New Zealand - Re-Export of Penicillins or Streptomycins in Dosage Forms
Since 2014, New Zealand Re-Export of Penicillins or Streptomycins in Dosage Forms was up 9.9% year on year. With $343,459.3 in 2019, the country was number 10 among other countries in Re-Export of Penicillins or Streptomycins in Dosage Forms. New Zealand is overtaken by Cyprus, which was ranked number 9 with $401,376.21 and is followed by Kuwait with $163,010. Italy topped the ranking with $158,707,704.07 in 2019, a decrease of 22% versus 2018. United States, United Arab Emirates and Saudi Arabia respectively ranked number 2, 3 and 4 in this ranking. Kenya recorded the best 5 years average growth at +205.7% per year, while Trinidad and Tobago witnessed the worst performance at -27.8% per year.
Loading...
| Date | US Dollars |
|---|---|
| 2019 | 343,459.30 |
| 2018 | 357,809.94 |
| 2017 | 271,899.41 |
| 2016 | 145,493.53 |
| 2015 | 402,948.19 |
How does New Zealand rank in Re-Export of Penicillins or Streptomycins in Dosage Forms?
| # | 27 Countries | US Dollars | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
Italy
|
158,707,704.07 | 2019 | -22.0 % | +57.7 % | View data | |
| 2 |
#2
United States
|
21,398,977.04 | 2019 | +3.5 % | +117.4 % | View data | |
| 9 |
#9
Cyprus
|
401,376.21 | 2019 | +42.1 % | +16.1 % | View data | |
| 10 |
#10
New Zealand
|
343,459.30 | 2019 | -4.0 % | +9.9 % | View data | |
| 11 |
#11
Kuwait
|
163,010.00 | 2017 | +23.4 % | NA | View data | |